CTS

LISLE, Ill., July 14, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) will release its earnings for the second quarter 2026 at approximately 8:00 a.m. (ET) on Tuesday, July 28, 2026. A conference call to discuss the results of the second quarter of 2026 with management is scheduled for Tuesday, July 28, 2026, at 10:00 a.m. (ET). The conference call can be accessed by registering online at CTS Corporation Q2 2026 Earnings Call. Analysts can access the call using the registration link Analyst registration, at which time registrants will receive dial-in information as well as a conference ID. A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at https://investors.ctscorp.com/news-events/events-and-presentations/ where it will be archived for one year. About CTSCTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides highly engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com. ContactAshish AgrawalVice President and Chief Financial Officer CTS Corporation4925 Indiana AvenueLisle, IL 60532USA Telephone: +1 (630) 577-8800E-mail: [email protected]

TD SYNNEX SNX reported non-GAAP earnings of $4.85 per share for the second quarter of fiscal 2026, beating the Zacks Consensus Estimate of $3.92 by 19.9%. The bottom line increased 62.2% year over year. Revenues of $19.58 billion surpassed the consensus mark of $16.84 billion by 16.2% and increased 31% from the year-ago quarter. The strong performance was driven by broad-based momentum across the Distribution and Hyve businesses. Non-GAAP gross billings climbed 33.4% year over year to a record $28.9 billion, reflecting continued demand across infrastructure, security and hyperscale programs. TD SYNNEX's Distribution business generated non-GAAP gross billings of $23.4 billion, up 22% year over year. Management highlighted broad-based strength across all regions and product categories, supported by strong demand, an expanding customer base and continued market-share gains. Distribution non-GAAP operating income rose 36% year over year to $434 million. Non-GAAP operating margin, as a percentage of gross billings, improved 19 basis points year over year to 1.85%, benefiting from favorable mix, disciplined cost management and modest gains from strategic inventory purchases. TD SYNNEX Corporation price-consensus-eps-surprise-chart | TD SYNNEX Corporation Quote Hyve Solutions remained the standout performer during the quarter. Non-GAAP gross billings surged 117% year over year to $5.5 billion, driven by increased manufacturing volumes from existing customers and continued strength in supply-chain services. Non-GAAP operating income for Hyve increased 89% year over year to $181 million. Manufacturing activities accounted for roughly two-thirds of Hyve's business, while supply-chain services represented approximately one-third. The company also announced plans to expand its U.S. manufacturing footprint by more than one million square feet to support future customer demand. Among product categories, Advanced Solutions revenues increased 43% year over year to $7.8 billion, benefiting from sustained demand in infrastructure and cybersecurity offerings. Endpoint Solutions revenues rose 17% year over year to $8.8 billion, supported by strong personal computer demand and higher average selling prices. Consolidated gross profit increased 28% year over year to $1.34 billion. However, gross margin contracted 16 basis points year over year to 6.84%, reflecting a higher contrib...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the electronic components & manufacturing stocks, including CTS (NYSE:CTS) and its peers. The sector could see higher demand as the prevalence of advanced electronics increases in industries such as automotive, healthcare, aerospace, and computing. The high-performance components and contract manufacturing expertise required for autonomous vehicles and cloud computing datacenters, for instance, will benefit companies in the space. However, headwinds include geopolitical risks, particularly U.S.-China trade tensions that could disrupt component sourcing and production as the Trump administration takes an increasingly antagonizing stance on foreign relations. Additionally, stringent environmental regulations on e-waste and emissions could force the industry to pivot in potentially costly ways. The 10 electronic components & manufacturing stocks we track reported an exceptional Q1. As a group, revenues beat analysts’ consensus estimates by 3.8% while next quarter’s revenue guidance was in line. Luckily, electronic components & manufacturing stocks have performed well with share prices up 27.6% on average since the latest earnings results. With roots dating back to 1896 and a global manufacturing footprint, CTS (NYSE:CTS) designs and manufactures sensors, connectivity components, and actuators for aerospace, defense, industrial, medical, and transportation markets. CTS reported revenues of $139.2 million, up 10.7% year on year. This print exceeded analysts’ expectations by 1.8%. Overall, it was a strong quarter for the company with a beat of analysts’ EPS and revenue estimates. “CTS delivered another quarter of strong performance, with diversified end-market sales up 18% year over year and modest growth in transportation,” said Kieran O’Sullivan, CEO of CTS Corporation. CTS achieved the highest full-year guidance raise of the whole group. Unsurprisingly, the stock is up 18.9% since reporting and currently trades at $64.55. Is now the time to buy CTS? Access our full analysis of the earnings results here, it’s free. As one of the world's largest printed circuit board manufacturers with facilities spanning North America and Asia, TTM Technologies (NASDAQ:TTMI) manufactures printed circuit boards (PCBs) and radio frequency (RF) components for aerospace, defense, automotive, and telecommunications...

In recent months, CTS has attracted strong support from analysts, with Zacks assigning it a Rank #1 (Strong Buy) and brokers collectively rating the stock as a strong buy based on earnings estimate revisions and recent EPS performance. This sustained positive sentiment in the research community highlights growing confidence in CTS’s earnings outlook and its ability to execute on current expectations. Next, we’ll examine how this sustained positive analyst sentiment might influence CTS’s existing investment narrative and risk-return profile. The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation. To own CTS today, you need to believe in its ability to convert exposure to smart, connected, and electrified technologies into durable earnings, while managing transportation softness and geopolitical pressures. The recent analyst support and strong 12 week price move reinforce confidence in near term execution but do not materially change the key short term catalyst, which is how effectively CTS can grow its higher margin medical and industrial businesses relative to transportation headwinds, nor the biggest risk around ongoing transportation demand weakness. The most relevant recent development to set against this improved sentiment is CTS’s Q1 2026 earnings release, where the company reported higher sales and EPS versus the prior year and modestly raised its full year revenue guidance to US$560 million to US$580 million. This update aligns with the idea that diversification into medical, industrial, and aerospace or defense can help offset transportation softness, but it also puts more attention on execution risk if trade tariffs, China exposure, or European competition were to intensify. Yet behind this positive narrative, investors should be aware of how prolonged transportation softness and China related pressures could... Read the full narrative on CTS (it's free!) CTS' narrative projects $639.6 million revenue and $89.0 million earnings by 2029. Uncover how CTS' forecasts yield a $58.00 fair value, a 15% downside to its current price. Simply Wall St Community members currently place CTS’s fair value between US$58 and US$61.86, based on 2 independent views. Set against the recent analyst optimism around earnings execution, this spread underlines how differently ma...

What a time it’s been for CTS. In the past six months alone, the company’s stock price has increased by a massive 46.2%, setting a new 52-week high of $61.90 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation. Is now the time to buy CTS, or should you be careful about including it in your portfolio? Dive into our full research report to see our analyst team’s opinion, it’s free. We’re happy investors have made money, but we're sitting this one out for now. Here are three reasons why CTS doesn't excite us and a stock we'd rather own. A company’s long-term sales performance is one signal of its overall quality. Any business can have short-term success, but a top-tier one grows for years. Unfortunately, CTS’s 4.3% annualized revenue growth over the last five years was mediocre. This was below our standard for the business services sector. With $554.8 million in revenue over the past 12 months, CTS is a small player in the business services space, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and numerous distribution channels. ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity). We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Over the last few years, CTS’s ROIC has unfortunately decreased. We like what management has done in the past, but its declining returns are perhaps a symptom of fewer profitable growth opportunities. CTS isn’t a terrible business, but it isn’t one of our picks. Following the recent surge, the stock trades at 26.1× forward P/E (or $61.90 per share). This valuation tells us a lot of optimism is priced in - we think there are better opportunities elsewhere. We’d recommend looking at one of our top digital advertising picks. ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies. Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that...

In late April 2026, CTS Corporation reported first-quarter 2026 results showing year-on-year growth in sales to US$139.23 million and net income to US$17.2 million, while also narrowing its full-year sales guidance range to US$560 million–US$580 million and reiterating its interest in acquisitions. Management’s emphasis on pursuing acquisitions to improve diversification and the quality of earnings gives investors a clearer view of how capital allocation could shape CTS’s future business mix. We’ll now examine how CTS’s stronger first-quarter performance and tightened full-year guidance could influence the company’s investment narrative. Outshine the giants: these 18 early-stage AI stocks could fund your retirement. To own CTS, you need to believe the company can keep shifting its revenue mix toward higher value sensor and actuator markets while managing cyclicality in transportation and geopolitical pressures. The latest first quarter beat and narrowed 2026 sales guidance appear supportive for the near term, but do not remove key risks around transportation softness, tariffs and medical product weakness, which still look like the most important swing factors for earnings over the next year. The most relevant update here is CTS’s decision to narrow its 2026 sales guidance range to US$560 million to US$580 million, alongside reiterating its appetite for acquisitions. This combination links the near term earnings catalyst of steadier top line visibility with the longer term goal of using M&A to deepen diversification away from more volatile transportation exposure and toward markets such as industrial, aerospace and medical. But while CTS’s diversification efforts are encouraging, investors should still be aware of how transportation softness and tariff risks could... Read the full narrative on CTS (it's free!) CTS' narrative projects $621.6 million revenue and $87.2 million earnings by 2029. This requires 4.7% yearly revenue growth and a roughly $22 million earnings increase from $65.3 million today. Uncover how CTS' forecasts yield a $54.00 fair value, a 4% downside to its current price. Two fair value estimates from the Simply Wall St Community currently span roughly US$54 to about US$64.6 per share, showing how far apart individual views on CTS’s potential can be. When you set those side by side with the recent guidance tightening and ongoing acquisition f...

Fabrinet FN is set to report its third-quarter fiscal 2026 results in May. 4. For the to-be-reported quarter, Fabrinet expects revenues between $1.15 billion and $1.2 billion, suggesting roughly 35% year-over-year growth at the midpoint. FN expects non-GAAP earnings in the $3.45-$3.60 per share range. The Zacks Consensus Estimate for revenues is pegged at $1.2 billion, indicating an increase of 37.1% from the year-ago quarter’s reported figure. The consensus mark for earnings is pegged at $3.58 per share, up a couple of cents over the past 30 days, indicating an increase of 42.1% from the year-ago-quarter’s reported figure. Image Source: Zacks Investment Research FN’s earnings have surpassed the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 2.16%. Fabrinet price-eps-surprise | Fabrinet Quote Let us see how things have shaped up for the upcoming announcement. Sluggish growth in the automotive end-market is expected to have hurt Fabrinet’s top-line growth in the third quarter of fiscal 2026. The company has expected revenues to grow sequentially in telecom, datacom and high-performance computing (HPC). Unfavorable forex is expected to hurt FN’s results. Fabrinet’s fiscal Q3 results are expected to have been driven by continued strong growth in non-optical communications, led by HPC, as customer demand scales and automated production capacity expands further. The company’s HPC segment has emerged as a key driver, with revenues surging to $86 million in the second quarter of fiscal 2026 from $15 million in the prior quarter, reflecting rapid hyperscale investments in AI data centers. Management indicated that this HPC program is slightly more than halfway through its ramp and is expected to exceed $150 million in revenues over the next couple of quarters, supported by additional automated production lines. However, automotive revenues are expected to have experienced a modest sequential decline, reflecting predictable program timing rather than weakening demand, and acting as a slight offset to overall growth. Industrial laser revenues are expected to have remained stable with steady year over year and sequential growth, supported by consistent demand conditions. Overall, the company’s ongoing diversification beyond optical communications, with strong contributions from automotive, industrial lasers and especiall...

Double-digit revenue growth of 11% was primarily driven by an 18% surge in diversified end markets, validating the long-term strategy to reduce reliance on automotive cycles. Gross margin expansion of 250 basis points resulted from a favorable shift in product mix toward higher-margin medical and industrial applications alongside operational improvements. Medical market strength was fueled by robust demand for diagnostic imaging and therapeutic applications, particularly in non-invasive aesthetics where capacity was recently expanded. Industrial performance saw a recovery in distribution and stable OEM demand, supported by secular trends in automation, connectivity, and energy efficiency. Transportation revenue remained stable with 3% growth, as the company focuses on powertrain-agnostic solutions like current sensing and smart actuators to mitigate light vehicle market softness. Management attributes the 1.1 book-to-bill ratio to strong momentum in industrial and medical sectors, offsetting temporary lulls in aerospace and defense funding. Full-year 2026 sales guidance is narrowed to $560 million to $580 million, assuming continued solid demand in diversified markets despite geopolitical uncertainties. Aerospace and defense revenue is expected to accelerate in the second half of 2026 as government funding normalizes following the February enactment of the appropriations bill. Commercial vehicle demand is projected to improve in the latter half of the year, driven by rising freight rates and pre-buy activity ahead of 2027 emission regulation changes. Management anticipates potential headwinds in the light vehicle market, with global production volumes forecasted to soften in the second half of the year. Strategic focus remains on 'Evolution 2030,' prioritizing organic growth investments in medical capacity and active pursuit of M&A to further enhance earnings quality. Management is closely monitoring Section 232 tariff changes on steel and aluminum and rising oil prices to ensure cost-neutral impacts through customer and supplier collaboration. Inflation in precious metals and oil-derived products like resin and epoxy is expected to create margin headwinds starting in late Q1 and moving into Q2. Foreign currency changes provided a $3 million favorable impact on sales and a $700 thousand benefit to gross margin in the first quarter. The company maintained a b...

CTS reported Q1 sales of $139 million, up 11% year-over-year, with adjusted diluted EPS of $0.62 (vs. $0.44) and a book-to-bill of 1.1, while adjusted gross margin improved to 39.5%, up 250 basis points. Diversification drove results: diversified sales rose 18% with particularly strong performance in medical (sales +28%, bookings +18%, book-to-bill 1.2) and industrial, while transportation showed modest stability (+3%) but held roughly $1.1 billion of booked business. CTS narrowed its 2026 guidance to $560–$580M in sales and $2.35–$2.45 adjusted EPS, generated $17 million of operating cash flow in Q1, repurchased $9 million of shares with $82 million remaining authorization, and finished the quarter with $91 million cash and $63 million of borrowings. Interested in CTS Corporation? Here are five stocks we like better. AI revolution: 3 stocks set to soar as technology evolves CTS (NYSE:CTS) reported first-quarter 2026 sales of $139 million, an 11% increase from the year-ago period, as the company cited double-digit growth in its diversified end markets and continued progress in its diversification strategy. President, CEO and Chairman Kieran O’ Sullivan said diversified sales rose 18% year-over-year, while transportation revenue increased 3% and showed “modest growth” and “stability” in the quarter. The company posted a first-quarter book-to-bill ratio of 1.1, which O’Sullivan said was up 4% versus the first quarter of 2025. CTS also reported margin improvement and higher profitability, with adjusted diluted earnings of $0.62 per share compared with $0.44 per share in the prior-year quarter. → Palantir Is Down 30%: Noise? Or a Signal to Accumulate? 7 Best AI Mutual Funds (and ETFs) to Sweep the AI Craze Chief Operating Officer Pratik Trivedi detailed results by end market, highlighting strong demand in medical and industrial, while noting that aerospace and defense bookings were lower year-over-year despite a “robust pipeline.” Medical: Sales were $25 million, up 28% year-over-year, with bookings up 18% and a book-to-bill ratio of 1.2. Trivedi said growth was broad-based, with particular strength in therapeutic applications. He also cited wins in medical ultrasound across multiple regions and a “large win” in non-invasive aesthetics. Aerospace and defense: Sales were $17 million, up 11% year-over-year, but book-to-bill was less than 1. Trivedi said CTS expect...

Image source: The Motley Fool. Wednesday, April 29, 2026 at 10 a.m. ET Chairman, President, and Chief Executive Officer — Kieran O'Sullivan Chief Financial Officer — Ashish Agrawal Chief Operating Officer — Pratik Trivedi Kieran O'Sullivan: Good morning, and thank you for joining us today. I am pleased to report a solid 2026 for CTS Corporation with diversified sales up double digits as we continue to execute our diversification strategy. We also saw strong bookings momentum in the industrial and medical markets. In transportation, we see stability in revenue with modest growth in the first quarter. Overall, with growth in key end markets and solid execution, we believe the company is well positioned to deliver on its strategic objectives. Ashish Agrawal, our CFO, will take us through the safe harbor statement and later through our financials. Pratik Trivedi, our COO, will provide an update on the progress in each of our end markets. Ashish? Ashish Agrawal: I would like to remind our listeners that this call contains forward-looking statements. These statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Additional information regarding these risks and uncertainties is contained in the press release issued today, and more information can be found in the company's SEC filings. To the extent that today's discussion refers to any non-GAAP measures under Regulation G, the required explanations and reconciliations are available with today's earnings press release and the supplemental slide presentation which can be found in the Investors section of the CTS Corporation website. I will now turn the discussion back over to our CEO, Kieran O'Sullivan. Kieran O'Sullivan: Thank you, Ashish. We finished the first quarter with sales of $139 million, representing a solid 11% increase compared to 2025. Our diversified end markets were up 18%. Transportation sales grew 3%. Our book-to-bill ratio for the first quarter was 1.1, up 4% compared to 2025. Looking at bookings performance, industrial bookings were strong, driven by stabilized OEM demand and the recovery in distribution. Medical bookings showed robust growth driven by continued strength in diagnostics and therapeutic applications. In aerospace and defense, we continue to have a robust pipeline of oppor...

Strong Results driven by Growth in Diversified End-Markets LISLE, Ill., April 29, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of highly engineered solutions that “Sense, Connect and Move,” today announced results for the first quarter of 2026. “CTS delivered another quarter of strong performance, with diversified end-market sales up 18% year over year and modest growth in transportation,” said Kieran O’Sullivan, CEO of CTS Corporation. “Our teams executed well, driving profitable growth, margin expansion, and strong cash generation. Diversification remains central to our strategy as we continue to strengthen our growth and quality of earnings." First Quarter 2026 Results Sales were $139 million in the first quarter of 2026, up 11% year-over-year. Sales to diversified end-markets increased 18%. Sales to the transportation market increased 3%. Net income was $17 million, or 12.4% of sales, compared to $13 million, or 10.6% of sales in the first quarter of 2025. Diluted EPS was $0.59, up 15 cents from $0.44 in the first quarter of 2025. Adjusted Gross margin was 39.5%, up 250 bps from 37.0% in the first quarter of 2025. Adjusted EBITDA margin was 23.0%, up 250 bps from 20.5% in the first quarter of 2025. Adjusted diluted EPS was $0.62, up 18 cents from $0.44 in the first quarter of 2025. Operating cash flow was $17.3 million, up $1.8 million from $15.5 million in the first quarter of 2025. 2026 Guidance Assuming the continuation of current market conditions, CTS is narrowing its previous guidance of 2026 sales from a range of $550-$580 million to $560-$580 million and adjusted diluted EPS from a range of $2.30-$2.45 to $2.35-$2.45. CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, ar...

LISLE, Ill. (AP) — LISLE, Ill. (AP) — CTS Corp. (CTS) on Wednesday reported net income of $17.2 million in its first quarter. On a per-share basis, the Lisle, Illinois-based company said it had profit of 59 cents. Earnings, adjusted for one-time gains and costs, came to 62 cents per share. The electronics manufacturer posted revenue of $139.2 million in the period. CTS expects full-year earnings in the range of $2.35 to $2.45 per share, with revenue in the range of $560 million to $580 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTS at https://www.zacks.com/ap/CTS